全文获取类型
收费全文 | 933444篇 |
免费 | 67851篇 |
国内免费 | 1338篇 |
专业分类
耳鼻咽喉 | 13001篇 |
儿科学 | 24436篇 |
妇产科学 | 23269篇 |
基础医学 | 133427篇 |
口腔科学 | 28351篇 |
临床医学 | 80836篇 |
内科学 | 183598篇 |
皮肤病学 | 19246篇 |
神经病学 | 72452篇 |
特种医学 | 37072篇 |
外国民族医学 | 79篇 |
外科学 | 152436篇 |
综合类 | 18062篇 |
现状与发展 | 1篇 |
一般理论 | 234篇 |
预防医学 | 61831篇 |
眼科学 | 21324篇 |
药学 | 72977篇 |
3篇 | |
中国医学 | 2162篇 |
肿瘤学 | 57836篇 |
出版年
2018年 | 9013篇 |
2017年 | 7077篇 |
2016年 | 7836篇 |
2015年 | 8936篇 |
2014年 | 12085篇 |
2013年 | 17642篇 |
2012年 | 24251篇 |
2011年 | 25227篇 |
2010年 | 14904篇 |
2009年 | 14344篇 |
2008年 | 24793篇 |
2007年 | 25859篇 |
2006年 | 26641篇 |
2005年 | 25588篇 |
2004年 | 24697篇 |
2003年 | 23728篇 |
2002年 | 23300篇 |
2001年 | 54846篇 |
2000年 | 56653篇 |
1999年 | 47049篇 |
1998年 | 10776篇 |
1997年 | 9509篇 |
1996年 | 9643篇 |
1995年 | 8976篇 |
1994年 | 8322篇 |
1993年 | 7626篇 |
1992年 | 35560篇 |
1991年 | 33975篇 |
1990年 | 32801篇 |
1989年 | 31921篇 |
1988年 | 29035篇 |
1987年 | 28294篇 |
1986年 | 26324篇 |
1985年 | 25185篇 |
1984年 | 17863篇 |
1983年 | 15158篇 |
1982年 | 7820篇 |
1981年 | 6779篇 |
1979年 | 15801篇 |
1978年 | 10620篇 |
1977年 | 9075篇 |
1976年 | 7894篇 |
1975年 | 8655篇 |
1974年 | 10485篇 |
1973年 | 9867篇 |
1972年 | 9369篇 |
1971年 | 8865篇 |
1970年 | 8431篇 |
1969年 | 7928篇 |
1968年 | 7206篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
William G. Breen Krishan R. Jethwa Nathan Y. Yu Grant M. Spears William S. Harmsen Robert C. Miller Jonathan B. Ashman William G. Rule Terence T. Sio Michelle A. Neben-Wittich Michael G. Haddock Amit Mahipal Mark J. Truty Christopher L. Hallemeier Kenneth W. Merrell 《Practical radiation oncology》2021,11(1):e63-e69
PurposeOur purpose was to determine the effect of chemoradiotherapy (CRT) on patient-reported quality of life (QOL) for patients with intact pancreas cancer.Methods and MaterialsWe reviewed a prospective QOL registry for patients with intact, clinically localized pancreatic ductal adenocarcinoma treated with CRT between June 2015 and November 2018. QOL was assessed pre-CRT (immediately before CRT, after neoadjuvant chemotherapy) and at the completion of CRT with the Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) and its component parts: FACT-General (FACT-G) and hepatobiliary cancer subscore (HCS). A minimally important difference from pre-CRT was defined as ≥ 6, 5, and 8 points for FACT-G, HCS, and FACT-Hep, respectively.ResultsOf 157 patients who underwent CRT, 100 completed both pre- and post-CRT surveys and were included in the primary analysis. Median age at diagnosis was 65 years (range, 23-90). National Comprehensive Cancer Network resectability status was resectable (3%), borderline resectable (40%), or locally advanced (57%). Folinic acid, 5-fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX) (75%) or gemcitabine and nab-paclitaxel (42%) were given for a median of 6 cycles (range, 0-42) before CRT. Radiation therapy techniques included 3-dimensional conformal (22%), intensity modulated photon (55%), and intensity modulated proton (23%) radiation therapy to a median dose of 50 Gy (range, 36-62.5). Concurrent chemotherapy was most commonly capecitabine (82%). Sixty-three patients (63%) had surgery after CRT. The mean decline in FACT-G, HCS subscale, and FACT-Hep from pre- to post-CRT was 3.5 (standard deviation [SD], 13.7), 1.7 (SD 7.8), and 5.2 (SD 19.4), respectively. Each of these changes were statistically significant, but did not meet the minimally important difference threshold. Pancreatic head tumor location was associated with decline in FACT-Hep. Nausea was the toxicity with the greatest increase from pre- to post-CRT by both physician-assessment and patient-reported QOL.ConclusionsFor patients with intact pancreatic adenocarcinoma, modern CRT is well tolerated with minimal decline in QOL during treatment. 相似文献
52.
The retroviral protease of human immunodeficiency virus (HIV) is an excellent target for antiviral inhibitors for treating HIV/AIDS. Despite the efficacy of therapy, current efforts to control the disease are undermined by the growing threat posed by drug resistance. This review covers the historical background of studies on the structure and function of HIV protease, the subsequent development of antiviral inhibitors, and recent studies on drug-resistant protease variants. We highlight the important contributions of Dr. Stephen Oroszlan to fundamental knowledge about the function of the HIV protease and other retroviral proteases. These studies, along with those of his colleagues, laid the foundations for the design of clinical inhibitors of HIV protease. The drug-resistant protease variants also provide an excellent model for investigating the molecular mechanisms and evolution of resistance. 相似文献
53.
54.
Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers 下载免费PDF全文
55.
56.
We report a case of intestinal obstruction in a 73-year-old woman caused by ileocolic intussusception. The underlying cause was a giant submucosal ulcerating lipoma (6?×?3.3?×?3.8 cm) extending from the superior mucosal lip of Bauhin’s valve. Abdominal ultrasonography showed a pathognomonic target-like mass appearing as multiple concentric rings. CT scan confirmed the diagnosis. Because of apparent obstruction, a laparotomy with right hemicolectomy and ileocolic anastomosis was performed. Lipomas most frequently occur in the cecum and ascending colon where they represent the most common submucosal mesenchymal tumor. They typically occur in elderly women with an incidence that varies from 0.15 to 0.56 %. Pain, rectal bleeding, and obstruction are typical symptoms. When faced with an intussusception in children, reduction with air per rectum can be performed. In adults, however, malignant cell spreading and seeding is of big concern. Since approximately 20–50 % of all underlying causes are malignant, explorative surgery is favored in adults. 相似文献
57.
58.
Torbj?rn Karlsson 《Upsala journal of medical sciences》2015,120(4):257-262
Background. Haemophagocytic lymphohistiocytosis (HLH) is a rare clinical syndrome characterized by fever, hepatosplenomegaly, cytopenia, and progressive multiple-organ failure. HLH in adults is often secondary to autoimmune diseases, cancer, or infections in contrast to familial HLH. Treatment of secondary HLH is directed against the triggering disease in addition to immunosuppressive therapy, the latter commonly according to the HLH-2004 protocol.Methods. We conducted a retrospective study to identify triggering diseases, disease-specific and immunosuppressive therapy administered, and prognosis in adult patients with secondary HLH. Patient data were collected from October 2010 to January 2015.Results. Ten adult patients with secondary HLH were identified. Seven were men, and the median age at diagnosis was 62 years. Five cases were triggered by malignant disease and five by infection. The median patient fulfilled five of the eight HLH-2004 diagnostic criteria. All patients fulfilled the criteria fever, cytopenia, and ferritin >500 µg/L. Median time from hospital admission to HLH diagnosis was 20 days. Four patients received immunosuppressive therapy according to the HLH-2004 protocol. The prognosis was dismal, especially for the patients with malignancy-associated HLH, of whom all died.Conclusion. HLH should be suspected in patients who present with fever, cytopenia, and ferritin >500 µg/L. Secondary HLH has a dismal prognosis. None of the patients with HLH triggered by malignancy survived. Achieving remission of the triggering disease seems to be important for a favourable outcome as, in all surviving patients, the haemophagocytic syndrome resolved after remission of the underlying infection. 相似文献
59.
60.